leisure time -WSS

leisure time

author：explore 2025-09-14 21:41:40 - browse：11443

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Judge rejects Trump's counterclaim against E. Jean Carroll

entertainment

WSS

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Use wet bulb globe temperature, not heat index, to protect workers

CDC launches VaccineFinder tool to locate Covid

Study: AI not yet building 'n

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Elevance, private equity launch primary care company

explore

leisure time

Gilead needs Arcellx more than ever

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CDC launches VaccineFinder tool to locate Covid

ChatGPT in medicine: STAT answers readers' burning questions

H5N1 communication has been strictly for the birds

Trump demands the U.S. pay no more for drugs than other countries … again

Sage's campaign to raise awareness of postpartum depression hits a nerve

Peter Hotez and the public health issue of online harassment

CDC launches VaccineFinder tool to locate Covid

Affirmative action in medical school literally saved lives

What nurses really want: sufficient staffing for patient care

leisure time

Hospitals use virtual reality to design more inclusive rooms for kids

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Researchers on aging grapple with how to calculate biological age

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Brain worms: The science behind RFK Jr.'s parasitic infection

entertainment

focus

hotspot

hotspot